| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 34551 |
| 1 | PREDNISONE | 29507 |
| 2 | METHOTREXATE SODIUM | 22228 |
| 3 | INFLIXIMAB | 22060 |
| 4 | METHOTREXATE | 20119 |
| 5 | RITUXIMAB | 18126 |
| 6 | ACETAMINOPHEN | 17240 |
| 7 | ETANERCEPT | 17012 |
| 8 | ERGOCALCIFEROL | 12691 |
| 9 | TOCILIZUMAB | 12183 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 7343 | 0.5422 |
| 1 | RITUXIMAB-ABBS | 1282 | 0.5099 |
| 2 | IVOSIDENIB | 563 | 0.4837 |
| 3 | OMADACYCLINE | 169 | 0.4734 |
| 4 | RITUXIMAB-PVVR | 436 | 0.4663 |
| 5 | ISAVUCONAZONIUM SULFATE | 667 | 0.3322 |
| 6 | BECAPLERMIN | 672 | 0.3189 |
| 7 | PURIXAN | 188 | 0.3176 |
| 8 | DEFIBROTIDE SODIUM | 687 | 0.3077 |
| 9 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES | 293 | 0.3030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 62819 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 46405 |
| 2 | RANK Ligand Inhibitor [EPC] | 34551 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27365 |
| 4 | Atypical Antipsychotic [EPC] | 21941 |
| 5 | Kinase Inhibitor [EPC] | 21857 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 21167 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 20070 |
| 8 | Benzodiazepine [EPC] | 20053 |
| 9 | Anti-epileptic Agent [EPC] | 17325 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthrax Protective Antigen-directed Antibody [EPC] | 1 | 0.5000 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 14 | 0.4516 |
| 2 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 5 | 0.3571 |
| 3 | Human Platelet-derived Growth Factor [EPC] | 672 | 0.3189 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 3538 | 0.3023 |
| 5 | Lead Chelator [EPC] | 18 | 0.3000 |
| 6 | Interferon gamma Blocker [EPC] | 13 | 0.2321 |
| 7 | RANK Ligand Inhibitor [EPC] | 34551 | 0.2091 |
| 8 | Lipoglycopeptide Antibacterial [EPC] | 158 | 0.2013 |
| 9 | Growth Hormone Secretagogue Receptor Agonist [EPC] | 1 | 0.2000 |